It accelerates the development of the chicken's brain, is beneficial to the protein synthesis of nerve cells and their respiratory chain, and at the same time stimulates the production of related hormones; it can effectively protect the central nervous system from toxic substances; it improves the rat's ability to resist hypoxia; it significantly accelerates the brain maturation of rats of several days old, and enhances the recognition ability of adult rats in the maze test; after use, the rotation speed of glucose in the blood-brain barrier is significantly accelerated.

It can dilate blood vessels and improve microcirculation

Extract from the above information

A short-acting non-selective alpha-receptor (alpha 1, alpha 2) blocker that can antagonize the effects of adrenaline and norepinephrine in the blood circulation, dilate blood vessels and reduce peripheral vascular resistance; antagonize the effects of catecholamines, and is used to diagnose and treat pheochromocytoma, but has little effect on the blood pressure of normal people or patients with essential hypertension; it can reduce peripheral vascular resistance, reduce cardiac afterload, reduce left ventricular end-diastolic pressure and pulmonary artery pressure, and increase cardiac output, and can be used to treat heart failure. Long-term tests have shown that phentolamine mesylate has no obvious carcinogenic, mutagenic and reproductive toxicity. In tests on rats, mice and rabbits, no teratogenic or embryotoxic effects of phentolamine mesylate were found.

Octreotide is a synthetic octapeptide compound and a 14-peptide human somatostatin analog. The pharmacological effects of octreotide are similar to those of natural hormones, but its inhibitory effects on growth hormone, glucagon and insulin are stronger. Similar to somatostatin, octreotide can also inhibit the response of LH to GnRH, reduce visceral blood flow, and inhibit the secretion of 5-HT, gastrin, vasoactive intestinal peptide, chymotrypsin, motilin and glucagon.